Thu, November 18, 2021
Wed, November 17, 2021
Tue, November 16, 2021
Mon, November 15, 2021
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021

Graig Suvannavejh Downgraded (TGTX) to Strong Sell and Decreased Target to $26 on, Nov 15th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-26-on-nov-15th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Graig Suvannavejh of Goldman Sachs, Downgraded "TG Therapeutics, Inc." (TGTX) to Strong Sell and Decreased Target from $33 to $26 on, Nov 15th, 2021.

Graig has made no other calls on TGTX in the last 4 months.



There is 1 other peer that has a rating on TGTX. Out of the 1 peers that are also analyzing TGTX, 0 agree with Graig's Rating of Hold.



This is the rating of the analyst that currently disagrees with Graig


  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $84 on, Monday, August 2nd, 2021

Publication Contributing Sources